These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 269641)

  • 41. Cancer of the cervix. A community approach.
    Rodenberger BM; Earle RP; Ingalls TH
    N Engl J Med; 1966 Apr; 274(16):896-8. PubMed ID: 17926871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Screening for uterine cervix cancer in Storstrøm, Vestsjaelland and Bornholm counties during 1979-1989].
    Lynge E; Poll P; Larsen J; Schultz H; Thommesen N
    Ugeskr Laeger; 1992 May; 154(19):1335-8. PubMed ID: 1598706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in mortality from uterine cancer in relation to mass screening.
    Christopherson WM; Scott MA
    Acta Cytol; 1977; 21(1):5-9. PubMed ID: 264759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [14 years of screening for cervix carcinoma in a family practice].
    van Gerven HP; Kant AC; Palm BT
    Ned Tijdschr Geneeskd; 1992 Nov; 136(47):2323-6. PubMed ID: 1461303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960-1984.
    Adami HO; Pontén J; Sparén P; Bergström R; Gustafsson L; Friberg LG
    Cancer; 1994 Jan; 73(1):140-7. PubMed ID: 8275416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Fee on Cervical Cancer Screening Attendance--ScreenFee, a Swedish Population-Based Randomised Trial.
    Alfonzo E; Andersson Ellström A; Nemes S; Strander B
    PLoS One; 2016; 11(3):e0150888. PubMed ID: 26986848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass screening for cervical cancer in Ostfold county of Norway 1959-77.
    Magnus K; Langmark F; Andersen A
    Int J Cancer; 1987 Mar; 39(3):311-6. PubMed ID: 3818122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimising the age, number of tests, and test interval for cervical screening in Canada.
    Shun-Zhang Y; Miller AB; Sherman GJ
    J Epidemiol Community Health; 1982 Mar; 36(1):1-10. PubMed ID: 7069349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A retrospective study of carcinoma of the uterine cervix and the value of cytological cervix studies in healthy women].
    Barentsz JO; Muizebelt F; van der Schee AC; Toonen-van Beek AA
    Ned Tijdschr Geneeskd; 1979 Nov; 123(45):1932-6. PubMed ID: 514382
    [No Abstract]   [Full Text] [Related]  

  • 50. Trends in cervical cancer and carcinoma in situ in Great Britain.
    Cook GA; Draper GJ
    Br J Cancer; 1984 Sep; 50(3):367-75. PubMed ID: 6466546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A population-based screening program for early detection of common cancers among women in India - methodology and interim results.
    Mishra GA; Dhivar HD; Gupta SD; Kulkarni SV; Shastri SS
    Indian J Cancer; 2015; 52(1):139-45. PubMed ID: 26838003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988.
    Sigurdsson K; Hrafnkelsson J; Geirsson G; Gudmundsson J; Salvarsdóttir A
    Gynecol Oncol; 1991 Oct; 43(1):64-70. PubMed ID: 1959790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Studies of screening, detection and mortality rates in mass screening for uterine cervical cancer in Shimane prefecture].
    Takahashi K; Moriyama M; Takamiya O; Shibukawa T; Iwanari O; Matsunaga I; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):377-82. PubMed ID: 3981047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cervical cancer incidence in elderly women-biology or screening history?
    Lynge E; Lönnberg S; Törnberg S
    Eur J Cancer; 2017 Mar; 74():82-88. PubMed ID: 28335890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pattern of presentation of carcinoma of the uterine cervix in East Anglia 1960 to 1975.
    de Bono AM; Pillers EM; Kirk NM
    Br J Obstet Gynaecol; 1978 Dec; 85(12):887-92. PubMed ID: 737154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Participation in the Dutch national screening programme for uterine cervic cancer higher after invitation by a general practitioner, especially in groups with a traditional low level of attendance].
    de Nooijer DP; de Waart FG; van Leeuwen AW; Spijker WW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2339-43. PubMed ID: 16261714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the impact of screening for cancer of the cervix.
    Miller AB
    IARC Sci Publ; 1986; (76):149-60. PubMed ID: 3570400
    [No Abstract]   [Full Text] [Related]  

  • 58. Pap smear screening and changes in cervical cancer mortality in Sweden.
    Mählck CG; Jonsson H; Lenner P
    Int J Gynaecol Obstet; 1994 Mar; 44(3):267-72. PubMed ID: 7909766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Twenty years' screening for cancer of the uterine cervix in Great Britain, 1964-84: further evidence for its ineffectiveness.
    Murphy MF; Campbell MJ; Goldblatt PO
    J Epidemiol Community Health; 1988 Mar; 42(1):49-53. PubMed ID: 3418286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.